ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

Fur New Centers Funded In ’88; More New Consortia On Way

November 25, 1988

NCI To Boost Investigator-Initiated Grants Using 5.7% Increase, Cuts In Contracts

February 9, 1996

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995